Results 1 to 10 of about 411 (87)
VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS [PDF]
Inhibitors of vascular endothelial growth factor receptor -2 (VEGFR-2) are crucial biological targets for the development of novel anticancer medications.
Helmy Sakr +3 more
doaj +1 more source
COMPUTATION DESIGN OF QUINAZOLINE-4(3H)-ON DERIVATIVES AS CYCLOOXYGENASE-2 (COX-2) INHIBITOR
The 3-(benzylideneamino)-2-(2,4-dichlorophenyl)-quinazoline-4(3H)-ones (BDCQ) are compounds developed as anticancer drugs and quinazolines. The activity and bioavailability of BDCQ derivatives as anticancer compounds that inhibit COX-2 can be predicted ...
Anita Puspa Widiyana
doaj +1 more source
The study is devoted to the study of acute toxicity of a new quinazoline compound — 3-[2-Oxo-2-(4-phenylpiperazine-1-yl)ethyl]quinazoline-4(3H)-one (VMA-10-21), promising as an antimicrobial agent active against opportunistic microorganisms.
N. M. Gabitova +3 more
doaj +1 more source
Synthesis Of Some Substituted 1,2,5-Oxadiazino [2-3,b] Quinazoline And Some 1,3-Oxazole Derivatives [PDF]
In this paper the synthesis of some 1,2,5- oxadiazino [2-3,b] quinazoline and some substituted 1,3- oxazole are reported, alanine and valine were reacted with benzoyle chloride in sodium hydroxide solution to give N- benzoyle alanine or valine (1,2 ...
Yassir S. Mohamad
doaj +1 more source
The dual c-Met/vascular endothelial growth factor receptor 2 (VEGFR-2) TK inhibition is a good strategy to overcome therapeutic resistance to small molecules VEGFR-2 inhibitors.
Abdelfattah Hassan +6 more
doaj +1 more source
Design and Molecular Docking Studies of Quinazoline Derivatives as Antiproliferation
Background: Nowadays, a lot of new active substances as anticancer agents have been developed. One of the protein targets of anticancer is selective cyclooxygenase-2 (COX-2). Selective COX-2 is the regulator of cell proliferation.
Anita Puspa Widiyana +4 more
doaj +1 more source
Structure-Activity Relationship and Docking Study of Non-Quinazoline EGFR/VEGFR Dual Inhibitors. A Review [PDF]
The dual inhibitors of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) have been developed as a promising strategy for cancer therapy.
Fatemeh Yousefbeyk, Saeed Ghasemi
doaj +1 more source
Occurrence of emerging organic micropollutants in water bodies and their effects are a concern related to quality of reused water. Advanced oxidation processes have demonstrated promising results to address this challenge.
Z. Amadou Yacouba +5 more
doaj +1 more source
Alkylation of 2,4-(1H,3H)-Quinazolinediones with Dialkyl Carbonates Under Microwave Irradiations
Alkylation is a very important chemical reaction which modifies the biological properties of drugs. Quinazolinedione derivatives are of considerable interest due to their wide array of pharmacological properties.We now report application of a practical ...
Martha Cecilia Meza +4 more
doaj +1 more source
QUINAZOLINE-BASED DERIVATIVES, AS AN ATTRACTIVE SCAFFOLD FOR DEVELOPING ANTICANCER AGENTS TARGETING DUAL VEGFR-2/EGFR INHIBITION [PDF]
Cancer remains one of the most challenging diseases worldwide despite tremendous advancements in sophisticated therapies. Among the molecular targets implicated in tumor development are epidermal growth factor receptor (EGFR) and vascular endothelial ...
Mohamed Ayman El-Zahabi +2 more
doaj +1 more source

